Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.110
+0.050 (4.72%)
Dec 20, 2024, 4:00 PM EST - Market closed
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $44.65 million as of December 20, 2024. Its market cap has decreased by -62.59% in one year.
Market Cap
44.65M
Enterprise Value
-48.78M
1-Year Change
-62.59%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $44.65M, a decrease of -92.29%. That is a compound annual growth rate of -50.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 44.65M | -68.62% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 42.10M |
| Gain Therapeutics | 41.64M |
| Cardio Diagnostics Holdings | 41.25M |
| Xilio Therapeutics | 41.23M |
| Exicure | 41.01M |
| ImmuCell | 40.82M |
| Q32 Bio | 40.68M |
| Rallybio | 40.50M |